The agreement will allow pharmacies to provide full-service specialty offerings for patients with complex chronic conditions and it will see Diplomat providing 24/7 access to specialty pharmacists and technicians.
The National Association of Chain Drug Stores Total Store Expo has announced participants of its Vision 2027 attraction at the 2016 TSE, which will be held Aug. 6-9 at the Boston Convention & Exhibition Center.
In the 2015 State of the Union address, President Barack Obama announced the launch of the Precision Medicine Initiative — a bold new research effort that can be actuated by MD Labs' Rxight, a pharmacogenetic program.
PhRMA said that the money poured into research has led to more medicines in clinical development than ever before and that the Food and Drug Administration has approved 550 medicines between 2000 and 2015.
A Forbes contributor on Monday offered an analysis of the recent record high in generics approvals by the Food and Drug Administration’s Office of Generic Drugs, and the importance that speedy approvals can play in helping patients. The analysis notes that speeding up FDA approval through user fee programs can be beneficial both for patients and manufacturers. (Forbes)
Whether you call the category by its old-school moniker “wearables” or the relatively new catch phrase “therables,” one thing is for sure: This niche market targeting first-adopter tech geeks and fitness fanatics might not be “niche” for much longer.
By interfacing with QS/1’s pharmacy management system, information doesn’t have to be entered twice when using the SureMed Guided Packing software, saving pharmacists time while ensuring accuracy in their hand-packing procedures.
NeuroMetrix is aiming its wearable pain relief device Quell at a customer it believes is underserved. “...There's this large population of Americans suffering from chronic disease, and current devices aren’t addressing what their needs are,” said SVP and general manager of consumer health Frank McGillin.
The drug is indicated as an adjunct to diet to treat high cholesterol in adults with primary hypercholesterolemia or mixed dyslipidemia, as well as treatment of adults with severe hypertriglyceridemia.